Active Implantable Medical Devices Market By Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016 To 2021)
The global Active Implantable Medical Devices market is anticipated to grow at a 7.76% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 18.43 billion in 2016 and is expected to reach USD 26.78 billion by 2021.
Browse Market data tables and in-depth TOC of the Global Active Implantable Medical Devices Market to 2021 at www.marketdataforecast.com/market-…ices-market-5027/
The Active Implantable Medical Device (AIMD) Directive 90/385/EEC defines an active implantable medical device as "any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure". As one of the highest risk categories of device, they are subject to severe regulatory controls both pre- and post-market.
The regulatory controls set out in the AIMD Directive also apply to any accessories that are used to enable the device to operate as intended, for examples leads, programmers, controllers, battery packs, software applications, implant kits and refill kits.
The demand for active implantable medical devices is rising due to increase in the prevalence of cardiovascular diseases and increase in the incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world.
Implantable cardioverter defibrillators and implantable cardiac pacemakers are the main medical devices used for the treatment of different cardiovascular conditions. High prevalence of cardiovascular diseases depicts an increase in the demand for these devices.
According to the World Health Organization WHO, globally, around 17.5 million people died due to cardiovascular diseases in 2012, while the number is anticipated to reach 23.3 million by 2030. Factors such as advancement in technological, increase in the prevalence of cardiovascular diseases, rise in the healthcare expenditures by patients and increase in the research and development activities are the major factors driving the growth of the global active implantable medical devices market.
However, the high cost of implantable medical devices and unfavorable reimbursement guidelines pose crucial challenge thereby limiting the adoption of active implantable medical devices solutions.
The global market for Active Implantable Medical Devices market is segmented into Product and Region. On the basis of Product, it is segmented into Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator and Implantable Hearing Devices.
Cardioverter defibrillators held the largest share in the active implantable medical devices market in 2016, due to the increase in the prevalence of cardiovascular diseases and high compliance for technologically advanced products. Transvenous implantable cardioverter desfibrillator which is further segmented into biventricular implantable cardioverter defibrillators, dual-chamber implantable cardioverter defibrillators.
Single-chamber implantable cardioverter defibrillators held the largest share in this market segment followed by subcutaneous implantable cardioverter defibrillators. The neurostimulators market is anticipated to witness the highest growth rate during the forecast period.
The demand for neurostimulators, especially deep brain stimulators is growing significantly across the globe. An increase in the prevalence of chronic pain, such as neuropathic pain, pain due to diabetes, arthritis pain and pain from injury has increased the demand for neurostimulators significantly.
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Middle East and Africa. North America held the largest share in the regional segment of the market.
The large share of this regional segment can be attributed to the growth in geriatric population, increase in the prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increase in the development of innovative and technologically advanced products, and increase in the healthcare expenditure in the region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, due to the rise in geriatric population, growth in the occurrence of chronic diseases, rise in healthcare spending, healthcare reforms for infrastructural development, growth in the demand for advanced technologies to develop advanced products, and less strict regulations.
Some of the key players dominating the active implantable medical devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S and Nurotron Biotechnology Co.
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information:Make an Inquiry about this report HERE!